Board Meetings for TORNTPHARM

Detailed list of historic and upcoming board meetings.

SymbolCompanyMeeting DatePurposeDescriptionLinks
TORNTPHARMTorrent Pharmaceuticals Limited25 Oct 2024TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 25-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2024 and Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited23 Jul 2024Financial Results/Other business mattersTo consider and approve the financial results for the period ended Jun 30, 2024 and other business matters
TORNTPHARMTorrent Pharmaceuticals Limited23 Jul 2024TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Jul-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited24 May 2024TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 24-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2024 and Dividend/Fund raising/Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited24 May 2024Financial Results/Dividend/Fund RaisingTo consider and approve the financial results for the period ended March 31, 2024, dividend and Fund Raising
TORNTPHARMTorrent Pharmaceuticals Limited02 Feb 2024TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Feb-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2023 and Dividend/Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited02 Feb 2024Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended December 31, 2023, dividend and other business matters
TORNTPHARMTorrent Pharmaceuticals Limited23 Oct 2023TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 23-Oct-2023 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended September 2023 and Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited23 Oct 2023Financial ResultsTo consider and approve the financial results for the period ended September 30, 2023 We would like to inform you that a meeting of the Board of Directors will be held on Monday, 23-Oct-23, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and half year ended on 30-Sep-23.
TORNTPHARMTorrent Pharmaceuticals Limited07 Aug 2023TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2023 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2023 .Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited30 May 2023TORRENT PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 30-May-2023 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2023 and Dividend/Fund raising/Other business.Board Meeting Intimation
TORNTPHARMTorrent Pharmaceuticals Limited30 May 2023Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2023, dividend and other business matters
TORNTPHARMTorrent Pharmaceuticals Limited25 Jan 2023Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended December 31, 2022, dividend and other business matters
TORNTPHARMTorrent Pharmaceuticals Limited21 Oct 2022Financial results/Other business mattersTorrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 21-Oct-2022 to consider financial statements for the period ended September 2022 and Other business matters
TORNTPHARMTorrent Pharmaceuticals Limited29 Jul 2022Financial results/Other business mattersTorrent Pharmaceuticals Limited has informed the Exchange about Board Meeting to be held on 29-Jul-2022 to consider financial statements for the period ended June 2022
Showing page 2 of 8 (111 total items)